Immunomedics Inc IMMU
We take great care to ensure that the data presented and summarized in this overview for IMMUNOMEDICS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in IMMU
Top Purchases
Top Sells
About IMMU
Insider Transactions at IMMU
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2020
|
Barbara Gayle Duncan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,244
-100.0%
|
-
|
|
Oct 23
2020
|
Charles M Baum Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,667
-100.0%
|
-
|
|
Oct 23
2020
|
Bryan Ball Chief Quality Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
-
|
|
Oct 23
2020
|
Khalid Islam Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Lorettta M Itri Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-100.0%
|
-
|
|
Oct 23
2020
|
Peter Barton Hutt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Scott A Canute Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Usama Malik Chief Fin. & Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,856
-100.0%
|
-
|
|
Oct 23
2020
|
Behzad Aghazadeh Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
26,250,000
-100.0%
|
-
|
|
Oct 23
2020
|
Behzad Aghazadeh Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Jun 18
2020
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,718
+17.75%
|
-
|
|
May 01
2020
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,750,000
+6.25%
|
$49,000,000
$28.5 P/Share
|
|
Mar 20
2020
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Dec 05
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,000,000
+7.55%
|
$34,000,000
$17.5 P/Share
|
|
Oct 03
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+2.17%
|
$7,000,000
$14.1 P/Share
|
|
Oct 02
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+4.35%
|
$13,000,000
$13.23 P/Share
|
|
Jun 28
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+1.18%
|
$3,250,000
$13.84 P/Share
|
|
Jun 27
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
350,000
+1.66%
|
$4,550,000
$13.68 P/Share
|
|
Jun 26
2019
|
Avoro Capital Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
400,000
+1.92%
|
$5,200,000
$13.25 P/Share
|
|
Jun 07
2019
|
Behzad Aghazadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,667
+41.7%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders